07 February 2022 Calym
RedTalks Season2#4: Could polatuzumab dethron...
05 January 2022 Calym
RedTalks Season2#3: Circulating tumor DNA (ct...
29 December 2021 Calym
CALYM: strong dynamics engaged with FINDMED
08 December 2021 Calym
AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING...
01 December 2021 Calym
A STRUCTURING INTEGRATING THE ENTIRE VALUE CH...
29 November 2021 Calym
Congratulations to the 2 new winners of the C...
24 November 2021 Calym
ANTICANCER CELL THERAPY GROUP AND INSTITUT CA...
02 November 2021 Calym
ISSUES IN LYMPHOMA RESEARCH
22 October 2021 Calym
14th edition of the Rendez-vous Carnot
20 October 2021 Calym
RedTalks Season2 #2: PDX a powerful tool of n...
11 October 2021 Calym
CALYM’s active role in the research eco...
03 October 2021 Calym
With OncoSTARTUPPER, participate in the Oncol...
24 September 2021 Calym
RedTalks Season2 #1: A macro view of the tumo...
15 September 2021 Calym
Carnot CALYM Institute Interactive Activity R...
31 May 2021 Calym
Launch of OncoSTART consortium supporting onc...
18 May 2021 Calym
RedTalks #9 : Epigenetic Bases and Therapy Ly...
19 March 2021 Calym
RedTalks #7: From 2 Cancer Centers to Industr...
09 March 2021 Calym
CALYM consortium, and SideROS are launching a...
02 March 2021 Calym
Partnership agreement between the Carnot CALY...
09 February 2021 Calym
A new framework agreement for CALYM
04 February 2021 Calym
RedTalks #6: Understanding T-cell lymphoma
18 January 2021 Calym
RedTalks #5: CD19 CAR T cells for B-cell NHL ...
16 December 2020 Calym
Step Pharma and Calym launch a partnership to...
Carnot CALYM institute, an academic consortium that aims at accelerating in...
11 December 2020 Calym
RedTalks #4 Driving toward precision medicine...